Novel Biomarkers For Cancer Diagnosis, Prediction Or Staging


The present invention relates to a method for predicting clinical outcome for a subject diagnosed with colorectal cancer, skin cancer, head and neck cancer or lung cancer. It also relates to a method for predicting whether a subject has a predisposition to develop such cancers as well as to a method for aiding the staging of such cancers in a subject. The methods of the present invention apply to the biomarkers MY05B and/or RAB8A and optionally in addition to RAB9A, RAB10, RAB11A, RAB25, CDC42, RAC and/or RhoA.

Download PDF
Document Preview
Document History
  • Publication: Feb 21, 2019
  • Application: Aug 10, 2018
    WO EP 2018071734 W
  • Priority: Aug 14, 2017
    LU LU 100371 A
  • Priority: Aug 14, 2017
    EP EP 17186112 A

Download Citation

Sign in to the Lens